EHMT1 and prostate carcinoma: This study has identified lysine 450 and 451 methylations as novel posttranslational modifications of EHMT1 and demonstrated the functional importance of dual-lysine demethylation as a molecular switch in reprogramming EHMT1 activity in prostate cancer cells.